Afya Ltd (AFYA) stock
Close on Nov 11, 2026Market cap $41.37MP/E 7.1Yield –
Afya Ltd grew revenue 11.9% to 3.70B BRL over fiscal 2025. Operating income rose 19.9% to 1.21B BRL, moving the operating margin from 30.6% to 32.8%. Free cash flow was 1.37B BRL, up 5.4% from a year earlier. At the latest close the market valued the company at 227.08M BRL, 7.1 times its earnings.
Key statistics
Valuation at the latest close; fundamentals over fiscal 2025, balances at Dec 31, 2025
Valuation
- Market cap
- 227.08M BRL
- P/E ratio
- 7.1
- Price to sales
- 0.06
- Price to book
- 0.05
- Dividend yield
- –
- Free cash flow yield
- 601.37%
Fundamentals
- Revenue
- 3.70B BRL
- Net income
- 752.46M BRL
- EPS, diluted
- 8.24 BRL
- Free cash flow
- 1.37B BRL
Trading
- Previous close
- $10.51
- Open
- $10.66
- Day's range
- $10.60 – $10.96
- Volume
- 134,962
- Average volume (20 days)
- 499,472
- Beta (5 years)
- 0.78
- RSI (14 days)
- 36.9
- Volatility (1 year)
- 43.2%
- Relative volume
- 0.44×
- WACC
- 11.5%
Market cap history
Month-end market cap since 2019, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 11, 2026. The S&P 500 is measured by the SPY fund.
| Period | AFYA | S&P 500 | Difference | AFYA per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -27.3% | -2.4% | −24.8 pts | ||
| 3 months | -21.0% | -1.2% | −19.8 pts | ||
| Year to date | -27.3% | +12.3% | −39.6 pts | ||
| 1 year | -22.3% | +12.4% | −34.8 pts | ||
| 3 years | -34.9% | +78.8% | −113.7 pts | -13.3% | +21.4% |
| 5 years | -27.1% | +75.2% | −102.2 pts | -6.1% | +11.9% |
Ten years at a glance
Fiscal years 2016 to 2025, BRL
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases Afya filed with the SEC as exhibits to Form 8-K or 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
About Afya
Services-Educational Services
Afya provides medical education and digital healthcare solutions through three primary operating segments: Undergraduate, Continuing Education, and Medical Practice Solutions. The company delivers undergraduate degree courses, specialized training programs, and continuing education for physicians and healthcare students. In addition to instructional activities, Afya develops and provides clinical software, telemedicine platforms, educational content, and digital health applications, generating revenue from student tuition fees, educational materials, and mobile application subscriptions. Its primary customer base comprises undergraduate medical students, healthcare practitioners, medical clinics, and healthcare service providers.
Company profile, executives and historyAfya stock: common questions
What is Afya's stock price?
AFYA closed at $10.73 on Nov 11, 2026, up 2.09% on the day.
What is Afya's market cap?
Afya was worth $41.37M at the close on Nov 11, 2026: the share price times the diluted shares outstanding.
What is AFYA's P/E ratio?
AFYA trades at 7.1 times earnings, based on diluted earnings per share of 8.24 BRL over fiscal 2025.
How much revenue does Afya make?
Afya reported revenue of 3.70B BRL for fiscal 2025, up 11.9% from a year earlier.
Does Afya pay a dividend?
No. Afya has not paid a cash dividend over the last twelve months.
How has AFYA stock performed over the past year?
Including dividends, AFYA returned -22.3% over the past year, against +12.4% for the S&P 500.
Who are Afya's competitors?
Companies most similar to Afya by business, industry and size include CVSA, GHC, LRN, EDU, STRA.
See a number that looks wrong?